Publicacions
-
Sánchez-García L, Serna N, Álamo P, Sala R, Céspedes MV, Roldan-Molina M, Sánchez-Chardi A, Unzueta U, Casanova I, Mangues R, Vázquez E and Villaverde A.
Self-assembling toxin-based nanoparticles as self-delivered antitumoral drugs.
JOURNAL OF CONTROLLED RELEASE . 274: 81-92. Nº de cites: 58
-
Palau F.
Fenotipos, genes y moléculas: la necesidad de investigar en enfermedades raras
SEBBM. Sociedad Española de Bioquímica y Biología Molecular . 195: 12-16.
-
Olivares M, Walker AW, Capilla A, Benítez-Páez A, Palau F, Parkhill J, Castillejo G and Sanz Y.
Gut microbiota trajectory in early life may predict development of celiac disease.
Microbiome . 6(1): 36-36. Nº de cites: 85
-
Izquierdo-Serra M, Martinez-Monseny T, Lopez L, Carrillo-Garcia J, Edo A, Ortigoza-Escobar JD, Garcia O, Cancho-Candela R, Carrasco-Marina ML, Gutierrez-Solana LG, Cuadras-Palleja D, Muchart-Lopez J, Montero-Sanchez R, Artuch-Iriberri R, Perez-Cerda C, Perez B, Pérez-Dueñas B, Macaya A, Fernandez-Fernandez JM and Serrano M.
Stroke-Like Episodes and Cerebellar Syndrome in Phosphomannomutase Deficiency (PMM2-CDG): Evidence for Hypoglycosylation-Driven Channelopathy
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 19(2): 619. Nº de cites: 36
-
de Pinho Favaro MT, Sanchez-Garcia L, Sanchez-Chardi A, Roldan-Molina M, Unzueta U, Serna N, Cano-Garrido O, Azzoni AR, Ferrer-Miralles N, Villaverde A and Vazquez E.
Protein nanoparticles are nontoxic, tuneable cell stressors.
NANOMEDICINE . 13(3): 255-268. Nº de cites: 10
-
Soto D, Olivella M, Grau C, Armstrong-Moron J, Alcon C, Gasull X, Gómez de Salazar M, Gratacòs-Batlle E, Ramos-Vicente D, Fernández-Dueñas V, Ciruela F, Bayés À, Sindreu C, López-Sala A, Garcia-Cazorla A and Altafaj X.
Rett-like Severe Encephalopathy Caused by a De Novo GRIN2B Mutation Is Attenuated by D-serine Dietary Supplement.
BIOLOGICAL PSYCHIATRY . 83(2): 160-172. Nº de cites: 5
-
Hector, RD, Kalscheuer, VM, Hennig, F, Leonard, H, Downs, J, Clarke, A, Benke, TA, Armstrong-Moron J, Pineda M, Bailey, MES and Cobb, SR.
CDKL5 variants: Improving our understanding of a rare neurologic disorder.
NEUROLOGY-GENETICS . 3(6): 200. Nº de cites: 52
-
Unzueta U, Serna N, Sánchez-García L, Roldan-Molina M, Sánchez-Chardi A, Mangues R, Villaverde AV and Vázquez E.
Engineering multifunctional protein nanoparticles by in vitro disassembling and reassembling of heterologous building blocks
Nanotechnology . 28(50): 505102-505102. Nº de cites: 12
-
Darling A, Tello C, Martí MJ, Garrido C, Aguilera-Albesa S, Tomás Vila M, Gastón I, Madruga M, González Gutiérrez L, Ramos Lizana J, Pujol M, Gavilán Iglesias T, Tustin K, Lin JP, Zorzi G, Nardocci N, Martorell-Sampol L, Lorenzo Sanz G, Gutiérrez F, García PJ, Vela L, Hernández Lahoz C, Ortigoza-Escobar JD, Marti-Sanchez L, Moreira F, Coelho M, Correia Guedes L, Castro Caldas A, Ferreira J, Pires P, Costa C, Rego P, Magalhães M, Stamelou M, Cuadras-Palleja D, Rodríguez-Blazquez C, Martínez-Martín P, Lupo V, Stefanis L, Pons R, Espinós C, Temudo T and Pérez-Dueñas B.
Clinical rating scale for pantothenate kinase-associated neurodegeneration: A pilot study.
MOVEMENT DISORDERS . 32(11): 1620-1630. Nº de cites: 16
-
Vidal-Falcó S, Brandi-Tarrau N, Pacheco-Fernández P, Gerotina E, Blasco-Perez L, Trotta JR, Derdak S, O'Callaghan-Gordo M, Garcia-Cazorla A, Pineda M and Armstrong-Moron J.
The utility of Next Generation Sequencing for molecular diagnostics in Rett syndrome.
SCIENTIFIC REPORTS . 7(1): 12288-12288. Nº de cites: 19